Paul Negulescu
Senior Vice President
PHYSIOLOGY
Vertex
Canada
Biography
Paul Negulescu idiscovered Vertex’s two medicines that treat the underlying cause of cystic fibrosis. Prior tojoining Vertex, Dr. Negulescu was Senior Vice President of Discovery Biology and a member of the executive team at Aurora Biosciences. When Vertex acquired Aurora, he was responsible for integrating Aurora’s research into Vertex. Dr. Negulescu received both his B.S. and Ph.D. from U.C. Berkeley in Physiology and carried out post-doctoral work at U.C. Berkeley and U.C. Irvine in the areas of ion channel biophysics and immunology.
Research Interest
biophysics and immunology